Serum lactate dehydrogenase and survival following cancer diagnosis
Open Access
- 15 October 2015
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 113 (9) , 1389-1396
Abstract
The BJC is owned by Cancer Research UK, a charity dedicated to understanding the causes, prevention and treatment of cancer and to making sure that the best new treatments reach patients in the clinic as quickly as possible. The journal reflects these aims. It was founded more than fifty years ago and, from the start, its far-sighted mission was to encourage communication of the very best cancer research from laboratories and clinics in all countries. The breadth of its coverage, its editorial independence and it consistent high standards, have made BJC one of the world's premier general cancer journals. Its increasing popularity is reflected by a steadily rising impact factor.Keywords
This publication has 51 references indexed in Scilit:
- An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab eraBlood, 2014
- Outcomes of patients with relapsed/refractory diffuse large B‐cell lymphoma with progression of lymphoma after autologous stem cell transplantation in the rituximab eraAmerican Journal of Hematology, 2013
- Serum tumor markers in the evaluation of male germ cell tumorsNature Reviews Urology, 2010
- Long-term survival is linked to serum LDH and partly to tumour LDH-5 in NSCLC.2010
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial dataThe Lancet Oncology, 2009
- Etoposide pharmacokinetics and survival in patients with small cell lung cancer: A multicentre studyLung Cancer, 2008
- Pyruvate Dehydrogenase Complex Activity Controls Metabolic and Malignant Phenotype in Cancer CellsJournal of Biological Chemistry, 2008
- A multicenter retrospective clinical study of CD5/CD10‐negative chronic B cell leukemiasAmerican Journal of Hematology, 2008
- Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemiaAmerican Journal of Hematology, 2007